Aptevo Therap
APVO----
Aptevo Therap (APVO)
Aptevo Therapeutics Inc., a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Aptevo Therap Analyst Rating
View MoreForecast & Rating
Jun 16, 2026Price forecast
$25.50480.87%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- benzinga_article · Jul 9 at 07:05 AM
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- benzinga_article · Jul 8 at 04:05 PM
12 Health Care Stocks Moving In Wednesday's After-Market Session
- StockTitan · Jun 29 at 11:05 PM
Aptevo Secures $1.5 Million Non-Dilutive Research Grant From the Andy Hill Care Fund to Advance APVO451, a Nectin-4-Targeted Trispecific Immunotherapy for Solid Tumors | APVO Stock News
- PUBT · Jun 25 at 11:25 AM
Aptevo Therapeutics posts investor presentation on multispecific immunotherapies for cancer, led by mipletamig in AML
- PUBT · Jun 22 at 10:45 AM
Aptevo Therapeutics files Form 3 initial beneficial ownership statement for Niowave Inc
- StockTitan · May 27 at 11:05 PM
Aptevo Therapeutics Appoints Mary J. Janatpour, Ph.D., as Senior Vice President & Chief Scientific Officer | APVO Stock News
